aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Pavmed Co., Ltd. is a commercial-stage, diversified medical technology company founded in 2004. Its core mission is to improve patient care and save lives through innovative medical devices. Pavmed's product portfolio includes advanced surgical instruments, diagnostic tools, and health monitoring systems. Key products include Lucid Diagnostics' EsoGuard, a mobile test unit for esophageal precancer detection, and Veris Health's integrated health monitoring solutions. The company focuses on revolutionizing patient care by challenging the status quo in the medical device industry.
Pavmed has made significant strides in medical technology, notably launching the first EsoGuard mobile test unit for early detection of esophageal precancer. This innovation underscores its commitment to enhancing diagnostic accuracy and accessibility. Pavmed's impact is evident in its contributions to early disease detection and patient monitoring, which have the potential to save lives and improve health outcomes. The company's leadership and strategic vision continue to drive its growth and influence in the medical technology sector.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Medical Devices
Tags
Healthtech
Model Types
Hardware
Revenue Type(s)
Transactional
Customer Type(s)
Consumers, Enterprise
Geographic Exposure
Global
When was Pavmed founded?
Pavmed was founded in 2014.
Where is Pavmed's headquarters located?
Pavmed's headquarters is located in New York City, NY, US.
When was Pavmed's last funding round?
Pavmed's most recent funding round was for $50M (USD) in April 2022.
How many employees does Pavmed have?
Pavmed has 124 employees as of Feb 6, 2024.
How much has Pavmed raised to-date?
As of July 05, 2023, Pavmed has raised a total of $69M (USD) since Apr 7, 2022.
Add Comparison
Total Raised to Date
$69M
USD
Last Update Apr 7, 2022
Last Deal Details
$50M
USD
Apr 7, 2022
Post Ipo Equity
Total Employees Over Time
124
As of Feb 2024
Pavmed Address
420 Lexington Ave
New York City,
New York
10017
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts